-
1
-
-
35949002429
-
Malignant astrocytic glioma: genetics, biology, and paths to treatment
-
Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA, Cavenee WK. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007; 21:2683-2710.
-
(2007)
Genes Dev
, vol.21
, pp. 2683-2710
-
-
Furnari, F.B.1
Fenton, T.2
Bachoo, R.M.3
Mukasa, A.4
Stommel, J.M.5
Stegh, A.6
Hahn, W.C.7
Ligon, K.L.8
Louis, D.N.9
Brennan, C.10
Chin, L.11
DePinho, R.A.12
Cavenee, W.K.13
-
2
-
-
0031963921
-
Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991
-
Davis FG, Freels S, Grutsch J, Barlas S, Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg. 1998; 88:1-10.
-
(1998)
J Neurosurg
, vol.88
, pp. 1-10
-
-
Davis, F.G.1
Freels, S.2
Grutsch, J.3
Barlas, S.4
Brem, S.5
-
3
-
-
75149195336
-
The transcriptional network for mesenchymal transformation of brain tumours
-
Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H, Lasorella A, Aldape K, Califano A, et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature. 2010; 463:318-325.
-
(2010)
Nature
, vol.463
, pp. 318-325
-
-
Carro, M.S.1
Lim, W.K.2
Alvarez, M.J.3
Bollo, R.J.4
Zhao, X.5
Snyder, E.Y.6
Sulman, E.P.7
Anne, S.L.8
Doetsch, F.9
Colman, H.10
Lasorella, A.11
Aldape, K.12
Califano, A.13
-
4
-
-
0036570062
-
Clinical relevance of MGMT in the treatment of cancer
-
Gerson SL. Clinical relevance of MGMT in the treatment of cancer. J Clin Oncol. 2002; 20:2388-2399.
-
(2002)
J Clin Oncol
, vol.20
, pp. 2388-2399
-
-
Gerson, S.L.1
-
5
-
-
84920792463
-
Treatment considerations for MGMT-unmethylated glioblastoma
-
Taylor JW, Schiff D. Treatment considerations for MGMT-unmethylated glioblastoma. Curr Neurol Neurosci Rep. 2015; 15:507.
-
(2015)
Curr Neurol Neurosci Rep
, vol.15
, pp. 507
-
-
Taylor, J.W.1
Schiff, D.2
-
6
-
-
34250160256
-
RNA maps reveal new RNA classes and a possible function for pervasive transcription
-
Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, Stadler PF, Hertel J, Hackermuller J, Hofacker IL, Bell I, Cheung E, Drenkow J, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science. 2007; 316:1484-1488.
-
(2007)
Science
, vol.316
, pp. 1484-1488
-
-
Kapranov, P.1
Cheng, J.2
Dike, S.3
Nix, D.A.4
Duttagupta, R.5
Willingham, A.T.6
Stadler, P.F.7
Hertel, J.8
Hackermuller, J.9
Hofacker, I.L.10
Bell, I.11
Cheung, E.12
Drenkow, J.13
-
7
-
-
84922244698
-
Roles of Long Non-Coding RNAs on Tumorigenesis and Glioma Development
-
Park JY, Lee JE, Park JB, Yoo H, Lee SH, Kim JH. Roles of Long Non-Coding RNAs on Tumorigenesis and Glioma Development. Brain Tumor Res Treat. 2014; 2:1-6.
-
(2014)
Brain Tumor Res Treat
, vol.2
, pp. 1-6
-
-
Park, J.Y.1
Lee, J.E.2
Park, J.B.3
Yoo, H.4
Lee, S.H.5
Kim, J.H.6
-
8
-
-
60149099385
-
Evolution and functions of long noncoding RNAs
-
Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009; 136:629-641.
-
(2009)
Cell
, vol.136
, pp. 629-641
-
-
Ponting, C.P.1
Oliver, P.L.2
Reik, W.3
-
9
-
-
65649092633
-
The genetic signatures of noncoding RNAs
-
Mattick JS. The genetic signatures of noncoding RNAs. PLoS Genet. 2009; 5:e1000459.
-
(2009)
PLoS Genet
, vol.5
-
-
Mattick, J.S.1
-
10
-
-
84863708888
-
Long non-coding RNA expression profiles predict clinical phenotypes in glioma
-
Zhang X, Sun S, Pu JK, Tsang AC, Lee D, Man VO, Lui WM, Wong ST, Leung GK. Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis. 2012; 48:1-8.
-
(2012)
Neurobiol Dis
, vol.48
, pp. 1-8
-
-
Zhang, X.1
Sun, S.2
Pu, J.K.3
Tsang, A.C.4
Lee, D.5
Man, V.O.6
Lui, W.M.7
Wong, S.T.8
Leung, G.K.9
-
11
-
-
84896053382
-
Long noncoding RNA profiles reveal three molecular subtypes in glioma
-
Li R, Qian J, Wang YY, Zhang JX, You YP. Long noncoding RNA profiles reveal three molecular subtypes in glioma. CNS Neurosci Ther. 2014; 20:339-343.
-
(2014)
CNS Neurosci Ther
, vol.20
, pp. 339-343
-
-
Li, R.1
Qian, J.2
Wang, Y.Y.3
Zhang, J.X.4
You, Y.P.5
-
12
-
-
0017716458
-
Thymidylate synthetase-a target enzyme in cancer chemotherapy
-
Danenberg PV. Thymidylate synthetase-a target enzyme in cancer chemotherapy. Biochim Biophys Acta. 1977; 473:73-92.
-
(1977)
Biochim Biophys Acta
, vol.473
, pp. 73-92
-
-
Danenberg, P.V.1
-
14
-
-
84953351370
-
lncRNAs and microRNAs with a role in cancer development
-
Liz J, Esteller M. lncRNAs and microRNAs with a role in cancer development. Biochim Biophys Acta. 2016; 1859:169-176.
-
(2016)
Biochim Biophys Acta
, vol.1859
, pp. 169-176
-
-
Liz, J.1
Esteller, M.2
-
15
-
-
84865138690
-
miRcode: a map of putative microRNA target sites in the long non-coding transcriptome
-
Jeggari A, Marks DS, Larsson E. miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics. 2012; 28:2062-2063.
-
(2012)
Bioinformatics
, vol.28
, pp. 2062-2063
-
-
Jeggari, A.1
Marks, D.S.2
Larsson, E.3
-
16
-
-
84919460718
-
miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer
-
Li T, Gao F, Zhang XP. miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer. Oncol Rep. 2015; 33:607-614.
-
(2015)
Oncol Rep
, vol.33
, pp. 607-614
-
-
Li, T.1
Gao, F.2
Zhang, X.P.3
-
17
-
-
51449092478
-
Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells
-
Galanti G, Fisher T, Kventsel I, Shoham J, Gallily R, Mechoulam R, Lavie G, Amariglio N, Rechavi G, Toren A. Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells. Acta Oncol. 2008; 47:1062-1070.
-
(2008)
Acta Oncol
, vol.47
, pp. 1062-1070
-
-
Galanti, G.1
Fisher, T.2
Kventsel, I.3
Shoham, J.4
Gallily, R.5
Mechoulam, R.6
Lavie, G.7
Amariglio, N.8
Rechavi, G.9
Toren, A.10
-
18
-
-
84900313975
-
Downregulation of ABCG2 protein inhibits migration and invasion in U251 glioma stem cells
-
Gong W, Wang Z, Wan Y, Shi L, Zhou Y. Downregulation of ABCG2 protein inhibits migration and invasion in U251 glioma stem cells. Neuroreport. 2014; 25:625-632.
-
(2014)
Neuroreport
, vol.25
, pp. 625-632
-
-
Gong, W.1
Wang, Z.2
Wan, Y.3
Shi, L.4
Zhou, Y.5
-
19
-
-
84883755139
-
Long non-coding RNAs: a new frontier in the study of human diseases
-
Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013; 339:159-166.
-
(2013)
Cancer Lett
, vol.339
, pp. 159-166
-
-
Shi, X.1
Sun, M.2
Liu, H.3
Yao, Y.4
Song, Y.5
-
20
-
-
84978131621
-
Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer
-
Huang NS, Chi YY, Xue JY, Liu MY, Huang S, Mo M, Zhou SL, Wu J. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer. Oncotarget. 2016; 7:37957-37965. doi: 10.18632/oncotarget.9364.
-
(2016)
Oncotarget
, vol.7
, pp. 37957-37965
-
-
Huang, N.S.1
Chi, Y.Y.2
Xue, J.Y.3
Liu, M.Y.4
Huang, S.5
Mo, M.6
Zhou, S.L.7
Wu, J.8
-
21
-
-
0344429906
-
MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer
-
Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, Thomas M, Berdel WE, Serve H, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003; 22:8031-8041.
-
(2003)
Oncogene
, vol.22
, pp. 8031-8041
-
-
Ji, P.1
Diederichs, S.2
Wang, W.3
Boing, S.4
Metzger, R.5
Schneider, P.M.6
Tidow, N.7
Brandt, B.8
Buerger, H.9
Bulk, E.10
Thomas, M.11
Berdel, W.E.12
Serve, H.13
-
22
-
-
84929956213
-
Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma
-
Ma KX, Wang HJ, Li XR, Li T, Su G, Yang P, Wu JW. Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma. Tumour Biol. 2015; 36:3355-3359.
-
(2015)
Tumour Biol
, vol.36
, pp. 3355-3359
-
-
Ma, K.X.1
Wang, H.J.2
Li, X.R.3
Li, T.4
Su, G.5
Yang, P.6
Wu, J.W.7
-
23
-
-
84989962712
-
Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling
-
Han Y, Wu Z, Wu T, Huang Y, Cheng Z, Li X, Sun T, Xie X, Zhou Y, Du Z. Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling. Cell Death Dis. 2016; 7:e2123.
-
(2016)
Cell Death Dis
, vol.7
-
-
Han, Y.1
Wu, Z.2
Wu, T.3
Huang, Y.4
Cheng, Z.5
Li, X.6
Sun, T.7
Xie, X.8
Zhou, Y.9
Du, Z.10
-
24
-
-
79961170994
-
A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?
-
Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011; 146:353-358.
-
(2011)
Cell
, vol.146
, pp. 353-358
-
-
Salmena, L.1
Poliseno, L.2
Tay, Y.3
Kats, L.4
Pandolfi, P.P.5
-
25
-
-
84899984643
-
Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer
-
Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB, Yin DD, Kong R, Xia R, Lu KH, Li JH, De W, Wang KM, Wang ZX. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer. 2014; 13:92.
-
(2014)
Mol Cancer
, vol.13
, pp. 92
-
-
Liu, X.H.1
Sun, M.2
Nie, F.Q.3
Ge, Y.B.4
Zhang, E.B.5
Yin, D.D.6
Kong, R.7
Xia, R.8
Lu, K.H.9
Li, J.H.10
De, W.11
Wang, K.M.12
Wang, Z.X.13
-
26
-
-
84938988506
-
Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205
-
Hirata H, Hinoda Y, Shahryari V, Deng G, Nakajima K, Tabatabai ZL, Ishii N, Dahiya R. Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205. Cancer Res. 2015; 75:1322-1331.
-
(2015)
Cancer Res
, vol.75
, pp. 1322-1331
-
-
Hirata, H.1
Hinoda, Y.2
Shahryari, V.3
Deng, G.4
Nakajima, K.5
Tabatabai, Z.L.6
Ishii, N.7
Dahiya, R.8
-
27
-
-
84888003905
-
Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1
-
Han Y, Liu Y, Zhang H, Wang T, Diao R, Jiang Z, Gui Y, Cai Z. Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1. FEBS Lett. 2013; 587:3875-3882.
-
(2013)
FEBS Lett
, vol.587
, pp. 3875-3882
-
-
Han, Y.1
Liu, Y.2
Zhang, H.3
Wang, T.4
Diao, R.5
Jiang, Z.6
Gui, Y.7
Cai, Z.8
-
28
-
-
79551568775
-
A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma
-
Ory B, Ramsey MR, Wilson C, Vadysirisack DD, Forster N, Rocco JW, Rothenberg SM, Ellisen LW. A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma. J Clin Invest. 2011; 121:809-820.
-
(2011)
J Clin Invest
, vol.121
, pp. 809-820
-
-
Ory, B.1
Ramsey, M.R.2
Wilson, C.3
Vadysirisack, D.D.4
Forster, N.5
Rocco, J.W.6
Rothenberg, S.M.7
Ellisen, L.W.8
-
29
-
-
84961848397
-
miR-203 inhibits cell proliferation and promotes cisplatin induced cell death in tongue squamous cancer
-
Lin J, Lin Y, Fan L, Kuang W, Zheng L, Wu J, Shang P, Wang Q, Tan J. miR-203 inhibits cell proliferation and promotes cisplatin induced cell death in tongue squamous cancer. Biochem Biophys Res Commun. 2016; 473:382-387.
-
(2016)
Biochem Biophys Res Commun
, vol.473
, pp. 382-387
-
-
Lin, J.1
Lin, Y.2
Fan, L.3
Kuang, W.4
Zheng, L.5
Wu, J.6
Shang, P.7
Wang, Q.8
Tan, J.9
-
30
-
-
84957582619
-
miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1
-
Zhang Y, Zhou SY, Yan HZ, Xu DD, Chen HX, Wang XY, Wang X, Liu YT, Zhang L, Wang S, Zhou PJ, Fu WY, Ruan BB, et al. miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1. Sci Rep. 2016; 6:19995.
-
(2016)
Sci Rep
, vol.6
, pp. 19995
-
-
Zhang, Y.1
Zhou, S.Y.2
Yan, H.Z.3
Xu, D.D.4
Chen, H.X.5
Wang, X.Y.6
Wang, X.7
Liu, Y.T.8
Zhang, L.9
Wang, S.10
Zhou, P.J.11
Fu, W.Y.12
Ruan, B.B.13
-
31
-
-
79952241662
-
miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression
-
Li J, Chen Y, Zhao J, Kong F, Zhang Y. miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Cancer Lett. 2011; 304:52-59.
-
(2011)
Cancer Lett
, vol.304
, pp. 52-59
-
-
Li, J.1
Chen, Y.2
Zhao, J.3
Kong, F.4
Zhang, Y.5
-
32
-
-
84928726641
-
MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2
-
Liao H, Bai Y, Qiu S, Zheng L, Huang L, Liu T, Wang X, Liu Y, Xu N, Yan X, Guo H. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2. Oncotarget. 2015; 6:8914-8928. doi: 10.18632/oncotarget.3563.
-
(2015)
Oncotarget
, vol.6
, pp. 8914-8928
-
-
Liao, H.1
Bai, Y.2
Qiu, S.3
Zheng, L.4
Huang, L.5
Liu, T.6
Wang, X.7
Liu, Y.8
Xu, N.9
Yan, X.10
Guo, H.11
-
33
-
-
84892963069
-
miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase
-
Zhou Y, Wan G, Spizzo R, Ivan C, Mathur R, Hu X, Ye X, Lu J, Fan F, Xia L, Calin GA, Ellis LM, Lu X. miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase. Mol Oncol. 2014; 8:83-92.
-
(2014)
Mol Oncol
, vol.8
, pp. 83-92
-
-
Zhou, Y.1
Wan, G.2
Spizzo, R.3
Ivan, C.4
Mathur, R.5
Hu, X.6
Ye, X.7
Lu, J.8
Fan, F.9
Xia, L.10
Calin, G.A.11
Ellis, L.M.12
Lu, X.13
-
34
-
-
0036796848
-
Thymidylate synthase protein expression and activity are related to the cell proliferation rate in human cancer cell lines
-
Derenzini M, Montanaro L, Trere D, Chilla A, Tazzari PL, Dall'Olio F, Ofner D. Thymidylate synthase protein expression and activity are related to the cell proliferation rate in human cancer cell lines. Mol Pathol. 2002; 55:310-314.
-
(2002)
Mol Pathol
, vol.55
, pp. 310-314
-
-
Derenzini, M.1
Montanaro, L.2
Trere, D.3
Chilla, A.4
Tazzari, P.L.5
Dall'Olio, F.6
Ofner, D.7
-
35
-
-
33847327128
-
Chronic oxaliplatinresistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines
-
Yang AD, Fan F, Camp ER, van Buren G, Liu W, Somcio R, Gray MJ, Cheng H, Hoff PM, Ellis LM. Chronic oxaliplatinresistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res. 2006; 12:4147-4153.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 4147-4153
-
-
Yang, A.D.1
Fan, F.2
Camp, E.R.3
van Buren, G.4
Liu, W.5
Somcio, R.6
Gray, M.J.7
Cheng, H.8
Hoff, P.M.9
Ellis, L.M.10
-
36
-
-
62449205665
-
Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition
-
Dallas NA, Xia L, Fan F, Gray MJ, Gaur P, van Buren G, 2nd, Samuel S, Kim MP, Lim SJ, Ellis LM. Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res. 2009; 69:1951-1957.
-
(2009)
Cancer Res
, vol.69
, pp. 1951-1957
-
-
Dallas, N.A.1
Xia, L.2
Fan, F.3
Gray, M.J.4
Gaur, P.5
van Buren, G.6
Samuel, S.7
Kim, M.P.8
Lim, S.J.9
Ellis, L.M.10
-
37
-
-
84924063355
-
The landscape of long noncoding RNAs in the human transcriptome
-
Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, Poliakov A, Cao X, Dhanasekaran SM, et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 2015; 47:199-208.
-
(2015)
Nat Genet
, vol.47
, pp. 199-208
-
-
Iyer, M.K.1
Niknafs, Y.S.2
Malik, R.3
Singhal, U.4
Sahu, A.5
Hosono, Y.6
Barrette, T.R.7
Prensner, J.R.8
Evans, J.R.9
Zhao, S.10
Poliakov, A.11
Cao, X.12
Dhanasekaran, S.M.13
-
38
-
-
0032764491
-
A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies
-
Britten CD, Rowinsky EK, Baker SD, Agarwala SS, Eckardt JR, Barrington R, Diab SG, Hammond LA, Johnson T, Villalona-Calero M, Fraass U, Statkevich P, Von Hoff DD, et al. A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies. Clin Cancer Res. 1999; 5:1629-1637.
-
(1999)
Clin Cancer Res
, vol.5
, pp. 1629-1637
-
-
Britten, C.D.1
Rowinsky, E.K.2
Baker, S.D.3
Agarwala, S.S.4
Eckardt, J.R.5
Barrington, R.6
Diab, S.G.7
Hammond, L.A.8
Johnson, T.9
Villalona-Calero, M.10
Fraass, U.11
Statkevich, P.12
Von Hoff, D.D.13
-
39
-
-
84961291563
-
Evaluation of novel imidazotetrazine analogues designed to overcome temozolomide resistance and glioblastoma regrowth
-
Ramirez YP, Mladek AC, Phillips RM, Gynther M, Rautio J, Ross AH, Wheelhouse RT, Sakaria JN. Evaluation of novel imidazotetrazine analogues designed to overcome temozolomide resistance and glioblastoma regrowth. Mol Cancer Ther. 2015; 14:111-119.
-
(2015)
Mol Cancer Ther
, vol.14
, pp. 111-119
-
-
Ramirez, Y.P.1
Mladek, A.C.2
Phillips, R.M.3
Gynther, M.4
Rautio, J.5
Ross, A.H.6
Wheelhouse, R.T.7
Sakaria, J.N.8
-
40
-
-
0020524559
-
A method of comparing the areas under receiver operating characteristic curves derived from the same cases
-
Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983; 148:839-843.
-
(1983)
Radiology
, vol.148
, pp. 839-843
-
-
Hanley, J.A.1
McNeil, B.J.2
-
41
-
-
16244366026
-
Index for rating diagnostic tests
-
Youden WJ. Index for rating diagnostic tests. Cancer. 1950; 3:32-35.
-
(1950)
Cancer
, vol.3
, pp. 32-35
-
-
Youden, W.J.1
|